Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis C

Free Subscription Articles published in J Virol Retrieve available abstracts of 21 articles: HTML format

Single Articles

September 2025
1. MATSUI C, Yuliandari P, Deng L, Abe T, et al
   Hepatitis C virus NS3/4A protease cleaves SPG20, a key regulator of lipid droplet turnover, to promote lipid droplet formation.
   J Virol. 2025 Sep 23:e0089025. doi: 10.1128/jvi.00890.
   PubMed     Abstract available
   
   
   
2. HAGA Y, Babu E P, Swiderska-Syn M, Reagan EK, et al
   Hepatitis C virus modified (S)E2(F442NYT)-mRNA-LNP candidate vaccine promotes helper CXCR5(+)T cells.
   J Virol. 2025 Sep 5:e0135525. doi: 10.1128/jvi.01355.
   PubMed     Abstract available
   
   
   
3. SCHWOERER MP, Carver S, Cafiero TR, Joyce B, et al
   Assessment of hepatitis C virus permissiveness in iteratively genetically humanized mice.
   J Virol. 2025 Sep 3:e0079325. doi: 10.1128/jvi.00793.
   PubMed     Abstract available
   
   
   June 2025
4. POWELL BH, Witwer KW, Meffert MK
   Cellular miRNAs and viruses: trends in miRNA sequestering and target de-repression.
   J Virol. 2025 Jun 18:e0091425. doi: 10.1128/jvi.00914.
   PubMed     Abstract available
   
   
   
5. BETZ A, Huang H-E, Gu Z, Colasanti O, et al
   Reconstitution of interferon regulatory factor 7 expression restores interferon beta induction in Huh7 cells.
   J Virol. 2025;99:e0070325.
   PubMed     Abstract available
   
   
   January 2025
6. FEDORCHENKO SV, Klimenko Z, Martynovich T, Solianyk I, et al
   Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks.
   J Virol. 2025 Jan 22:e0184324. doi: 10.1128/jvi.01843.
   PubMed     Abstract available
   
   
   June 2024
7. LIU J, Ito M, Liu L, Nakashima K, et al
   Involvement of ribosomal protein L17 and Y-box binding protein 1 in the assembly of hepatitis C virus potentially via their interaction with the 3' untranslated region of the viral genome.
   J Virol. 2024 Jun 20:e0052224. doi: 10.1128/jvi.00522.
   PubMed     Abstract available
   
   
   March 2024
8. TAMURA T, Yamamoto H, Ogino S, Morioka Y, et al
   A rapid and versatile reverse genetics approach for generating recombinant positive-strand RNA viruses that use IRES-mediated translation.
   J Virol. 2024;98:e0163823.
   PubMed     Abstract available
   
   
   February 2024
9. FRERICKS N, Brown RJP, Reinecke BM, Herrmann M, et al
   Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.
   J Virol. 2024 Feb 6:e0192123. doi: 10.1128/jvi.01921.
   PubMed     Abstract available
   
   
   January 2024
10. CASIANO MATOS J, Harichandran K, Tang J, Sviridov DO, et al
    Hepatitis C virus E1 recruits high-density lipoprotein to support infectivity and evade antibody recognition.
    J Virol. 2024 Jan 4:e0084923. doi: 10.1128/jvi.00849.
    PubMed     Abstract available
    
    
    December 2023
11. HAGA Y, Meyer K, Sung MMH, Reagan EK, et al
    Hepatitis C virus modified sE2(F442NYT) as an antigen in candidate vaccine facilitates human immune cell activation.
    J Virol. 2023 Dec 12:e0180923. doi: 10.1128/jvi.01809.
    PubMed     Abstract available
    
    
    
12. GOBRAN ST, Pagliuzza A, Khedr O, Fert A, et al
    DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people.
    J Virol. 2023 Dec 5:e0110523. doi: 10.1128/jvi.01105.
    PubMed     Abstract available
    
    
    November 2023
13. BAJPAI PS, Collignon L, Solund C, Madsen LW, et al
    Full-length sequence analysis of hepatitis C virus genotype 3b strains and development of an in vivo infectious 3b cDNA clone.
    J Virol. 2023 Nov 21:e0092523. doi: 10.1128/jvi.00925.
    PubMed     Abstract available
    
    
    October 2023
14. LI Y, Yang Y, Li T, Wang Z, et al
    Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection.
    J Virol. 2023 Oct 3:e0109023. doi: 10.1128/jvi.01090.
    PubMed     Abstract available
    
    
    September 2023
15. NEPAL S, Holmstrom ED
    Single-molecule-binding studies of antivirals targeting the hepatitis C virus core protein.
    J Virol. 2023 Sep 29:e0089223. doi: 10.1128/jvi.00892.
    PubMed     Abstract available
    
    
    
16. FELLENBERG J, Dubrau D, Isken O, Tautz N, et al
    Packaging defects in pestiviral NS4A can be compensated by mutations in NS2 and NS3.
    J Virol. 2023;97:e0057223.
    PubMed     Abstract available
    
    
    June 2023
17. PANIGRAHI M, Palmer MA, Wilson JA
    Enhanced Virus Translation Enables miR-122-Independent Hepatitis C Virus Propagation.
    J Virol. 2023 Jun 20:e0085821. doi: 10.1128/jvi.00858.
    PubMed     Abstract available
    
    
    
18. AVULA K, Singh B, Samantaray S, Syed GH, et al
    The Early Secretory Pathway Is Crucial for Multiple Aspects of the Hepatitis C Virus Life Cycle.
    J Virol. 2023 Jun 20:e0018023. doi: 10.1128/jvi.00180.
    PubMed     Abstract available
    
    
    
19. TOON K, Kalemera MD, Palor M, Rose NJ, et al
    GB Virus B and Hepatitis C Virus, Distantly Related Hepaciviruses, Share an Entry Factor, Claudin-1.
    J Virol. 2023 Jun 13:e0046923. doi: 10.1128/jvi.00469.
    PubMed     Abstract available
    
    
    
20. ABE T, Marutani Y, Deng L, Matsui C, et al
    Hepatitis C Virus Disrupts Annexin 5-Mediated Occludin Integrity through Downregulation of Protein Kinase Calpha (PKCalpha) and PKCeta Expression, Thereby Promoting Viral Propagation.
    J Virol. 2023 Jun 5:e0065523. doi: 10.1128/jvi.00655.
    PubMed     Abstract available
    
    
    April 2023
21. WOLFISBERG R, Holmbeck K, Billerbeck E, Thorselius CE, et al
    Molecular Determinants of Mouse Adaptation of Rat Hepacivirus.
    J Virol. 2023;97:e0181222.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.